Bioscience has been growing thanks to Colorado State University’s two superclusters aimed at speeding the transfer of innovative new technologies to the marketplace. One focuses on cancer research and the other emphasizes infectious disease.
The superclusters recently have spawned four bioscience companies, Diazamed, KromaTiD, VetDC and Avant Microsensors. CSU researchers have generated 157 new bioscience inventions in the past two years, according to CSU Ventures.
In the cancer supercluster, Diazamed makes a compound that coats stents to keep them working properly amid complications such as clotting. VetDC uses the Animal Cancer Center’s research capacities to identify promising cancer therapies for animals.
KromaTiD is developing methods to detect chromosomal inversions, which are genetic abnormalities associated with cancers and developmental disorders. The Colorado Institute for Drug, Device and Diagnostic Development recently announced that it would back the company with investment and